Trials / Conditions / Anemia, Refractory, With Excess of Blasts
Anemia, Refractory, With Excess of Blasts
4 registered clinical trials studyying Anemia, Refractory, With Excess of Blasts.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Terminated | IGF-MTX Conjugate in the Treatment of Myelodysplastic Syndrome NCT03175978 | IGF Oncology, LLC | Phase 1 / Phase 2 |
| Withdrawn | T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies NCT01163201 | Masonic Cancer Center, University of Minnesota | Phase 1 / Phase 2 |
| Completed | Brentuximab Vedotin in Patients With CD30-positive Nonlymphomatous Malignancies NCT01461538 | Seagen Inc. | Phase 2 |
| Completed | Evaluation of the Anti-CD-33 Immunotoxin Hum-195/rGel in Patients With Advanced Myeloid Malignancies NCT00038051 | M.D. Anderson Cancer Center | Phase 1 |